Zobrazeno 1 - 10
of 103
pro vyhledávání: '"J. Prade"'
Autor:
H.M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech
Publikováno v:
Contemporary Clinical Trials Communications, Vol 22, Iss , Pp 100770- (2021)
Background: Tumor necrosis factor inhibitors (TNFi) signify a major advance in the treatment of rheumatoid arthritis (RA). However, treatment success initially remains uncertain as approximately half of the patients do not respond adequately to TNFi.
Externí odkaz:
https://doaj.org/article/903233897b6f4e2cae77e9c731c2225b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 17, Iss 4, Pp 2131-2139 (2023)
Scrub typhus (ST) is a re-emerging zoonotic disease caused by Orientia tsutsugamushi and is transmitted by chiggers. Serological tests targeting IgM and/or IgG antibodies play a major role in the detection of ST cases. Orientia 56kDa genome is common
Externí odkaz:
https://doaj.org/article/a9245e83dd884c46a25622249c751eb7
Autor:
M. Sergeeva, J. A. P. Da Silva, Melanie Hagen, Stephanie Finzel, S. Strobelt, Georg Schett, J. Prade, Axel J. Hueber, Reinhard E. Voll, A. Doerfler, Jürgen Rech, Hannah Schenker, Frank Behrens, Christoph Baerwald, Eugen Feist, A. Kleyer, L. Valor, M. Selvakumar, David Simon, Koray Tascilar, Nemanja Damjanov, L. Konerth, Andreas Hess, Verena Schönau
Publikováno v:
Annals of the Rheumatic Diseases. 79:135-136
Background:We have previously observed in RA patients that central nervous system (CNS) response to compression of a painful joint, measured using functional MRI (fMRI) of the brain as the number of blood oxygen level dependent (BOLD) signal positive
Autor:
Verena Schönau, Jürgen Rech, A. Doerfler, Stephanie Finzel, M. Sergeeva, L. Valor, S. Strobelt, David Simon, Koray Tascilar, Nemanja Damjanov, Frank Behrens, Andreas Hess, Christoph Baerwald, J. Prade, Melanie Hagen, Georg Schett, J. A. P. Da Silva, Eugen Feist, L. Konerth, Axel J. Hueber, M. Selvakumar, Reinhard E. Voll, Hannah Schenker, A. Kleyer
Publikováno v:
Annals of the Rheumatic Diseases. 79:77-78
Background:Tumor necrosis factor inhibitors have revolutionized the treatment of rheumatoid arthritis (RA). However, only about 50% of the patients respond well to TNF inhibitors. Therefore, markers that predict response to TNF inhibitors are valuabl
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Selvakumar, Verena Schönau, Stephanie Finzel, David Simon, Koray Tascilar, Nemanja Damjanov, Melanie Hagen, L. Valor, Andreas Hess, A. Doerfler, Frank Behrens, Christoph Baerwald, Eugen Feist, S. Strobelt, Axel J. Hueber, J. A. P. Da Silva, Jürgen Rech, J. Prade, Georg Schett, Reinhard E. Voll, A. Kleyer, Hannah Schenker, M. Sergeeva, L. Konerth
Publikováno v:
Annals of the Rheumatic Diseases. 79:956.1-956
Background:Personalization of RA treatment is not optimal due to lack of predictors. We previously demonstrated in RA patients that central nervous system (CNS) pain response to tender joint compression, measured by using functional MRI (fMRI) of the
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20837- (2023)
This article focuses on the approximate controllability of impulsive neutral stochastic integrodifferential inclusions in Hilbert spaces. We used resolvent operators, fixed point approaches, and semigroup theory to achieve the article's main results.
Externí odkaz:
https://doaj.org/article/c12223a3aa6442d6beafe01763053e88
Autor:
Andreas Hess, Matthias Englbrecht, Eugen Feist, Christoph Baerwald, J. Prade, L. Konerth, Bettina Bannert, Axel J. Hueber, M. Sergeeva, Reinhard E. Voll, A. Doerfler, Julie Rösch, Hannah Schenker, Jürgen Rech, A. Kleyer, Michaela Reiser, Georg Schett
Publikováno v:
Poster Presentations.
Background Tumor necrosis factor inhibitors (TNFi) signify a major advance in the treatment of rheumatoid arthritis (RA). However, treatment success initially remains uncertain as one third of patients do not respond adequately to TNFi. Objectives We
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.